Open AccessLong-term proton pump inhibitor use is a risk factor for mortality in patients hospitalized for COVID-19
Author(s) -
Ahmet Yozgat,
Benan Kasapoğlu,
Güray Can,
Alpaslan Tanoğlu,
Yusuf Serdar Sakin,
Kadir Serkan Yalçın,
Müjgan Gürler,
Mustafa Kaplan,
Mehmet Göktürk Kaban,
Mehmet Kirsoy,
Umut Kara,
Murat Kekilli
Publication year - 2021
Publication title -
turkish journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.277
H-Index - 27
eISSN - 1303-6165
pISSN - 1300-0144
DOI - 10.3906/sag-2103-80
Subject(s) - medicine , covid-19 , proton pump inhibitor , risk factor , retrospective cohort study , intubation , disease , surgery , infectious disease (medical specialty)
The aim of this study is to evaluate whether the long-term (≥4 weeks) use of proton pump inhibitors (PPIs) is a risk factor for intubation requirement and mortality in patients hospitalized for COVID-19.